Chemotherapy of Chagas Disease: Status and New Developments

Hugo      Cerecetto; Mercedes      Gonzalez

Abstract

Chagas disease is a major parasitic problem in developing countries in Central and South America. Chemotherapy for such disease is still insufficient and not effective in its chronic part. Many efforts have been made in recent years to know more about possible new biochemical targets to design new selective drugs. This paper reviews old therapeutic approaches -Nifurtimox, Benznidazole and related compounds- and the latest rationally developed drugs that prove to be active against different parasitic forms

Keywords: chemotherapy of chagas disease

« Previous Next »

Rights & Permissions Print Cite

Current Topics in Medicinal Chemistry

Title: Chemotherapy of Chagas Disease: Status and New Developments

Volume: 2 Issue: 11

Author(s): Hugo Cerecetto and Mercedes Gonzalez

Affiliation:

Keywords: chemotherapy of chagas disease

Abstract: Chagas disease is a major parasitic problem in developing countries in Central and South America. Chemotherapy for such disease is still insufficient and not effective in its chronic part. Many efforts have been made in recent years to know more about possible new biochemical targets to design new selective drugs. This paper reviews old therapeutic approaches -Nifurtimox, Benznidazole and related compounds- and the latest rationally developed drugs that prove to be active against different parasitic forms

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Cerecetto Hugo and Gonzalez Mercedes, Chemotherapy of Chagas Disease: Status and New Developments, Current Topics in Medicinal Chemistry 2002; 2 (11) . https://dx.doi.org/10.2174/1568026023393066

DOI https://dx.doi.org/10.2174/1568026023393066	Print ISSN 1568-0266
Publisher Name Bentham Science Publisher	Online ISSN 1873-4294

About this journal

Call for Papers in Thematic Issues

Submission closes on : 24 September, 2024

Chemistry Based on Natural Products for Therapeutic Purposes

The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more

Guest Editor(s): Parag Jain

Submission closes on : 28 July, 2024

Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design

Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more

Guest Editor(s): Igor J. Dos Santos Nascimento

Submission closes on : 13 August, 2024

Drug Discovery in the Age of Artificial Intelligence

In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more

Guest Editor(s): Liangxu Xie

Submission closes on : 31 December, 2024

From Biodiversity to Chemical Diversity: Focus of Flavonoids

Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more

Guest Editor(s): Marcello Iriti